IBDEI05J ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7127,1,3,0)
 ;;=3^Oth Plastic Surgery
 ;;^UTILITY(U,$J,358.3,7127,1,4,0)
 ;;=4^V50.1
 ;;^UTILITY(U,$J,358.3,7127,2)
 ;;=^87802
 ;;^UTILITY(U,$J,358.3,7128,0)
 ;;=368.8^^37^411^39
 ;;^UTILITY(U,$J,358.3,7128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7128,1,3,0)
 ;;=3^Oth Specific Visual Disturbances
 ;;^UTILITY(U,$J,358.3,7128,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,7128,2)
 ;;=^88172
 ;;^UTILITY(U,$J,358.3,7129,0)
 ;;=368.13^^37^411^40
 ;;^UTILITY(U,$J,358.3,7129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7129,1,3,0)
 ;;=3^Photophobia
 ;;^UTILITY(U,$J,358.3,7129,1,4,0)
 ;;=4^368.13
 ;;^UTILITY(U,$J,358.3,7129,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,7130,0)
 ;;=998.59^^37^411^41
 ;;^UTILITY(U,$J,358.3,7130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7130,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,7130,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,7130,2)
 ;;=^97081
 ;;^UTILITY(U,$J,358.3,7131,0)
 ;;=368.03^^37^411^5
 ;;^UTILITY(U,$J,358.3,7131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7131,1,3,0)
 ;;=3^Amblyopia,Refractive
 ;;^UTILITY(U,$J,358.3,7131,1,4,0)
 ;;=4^368.03
 ;;^UTILITY(U,$J,358.3,7131,2)
 ;;=^265363
 ;;^UTILITY(U,$J,358.3,7132,0)
 ;;=367.31^^37^411^6
 ;;^UTILITY(U,$J,358.3,7132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7132,1,3,0)
 ;;=3^Anisometropia
 ;;^UTILITY(U,$J,358.3,7132,1,4,0)
 ;;=4^367.31
 ;;^UTILITY(U,$J,358.3,7132,2)
 ;;=^7839
 ;;^UTILITY(U,$J,358.3,7133,0)
 ;;=367.20^^37^411^7
 ;;^UTILITY(U,$J,358.3,7133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7133,1,3,0)
 ;;=3^Astigmatism,NOS
 ;;^UTILITY(U,$J,358.3,7133,1,4,0)
 ;;=4^367.20
 ;;^UTILITY(U,$J,358.3,7133,2)
 ;;=^11141
 ;;^UTILITY(U,$J,358.3,7134,0)
 ;;=367.0^^37^411^31
 ;;^UTILITY(U,$J,358.3,7134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7134,1,3,0)
 ;;=3^Hypermetropia
 ;;^UTILITY(U,$J,358.3,7134,1,4,0)
 ;;=4^367.0
 ;;^UTILITY(U,$J,358.3,7134,2)
 ;;=^60139
 ;;^UTILITY(U,$J,358.3,7135,0)
 ;;=367.1^^37^411^36
 ;;^UTILITY(U,$J,358.3,7135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7135,1,3,0)
 ;;=3^Myopia
 ;;^UTILITY(U,$J,358.3,7135,1,4,0)
 ;;=4^367.1
 ;;^UTILITY(U,$J,358.3,7135,2)
 ;;=^80671
 ;;^UTILITY(U,$J,358.3,7136,0)
 ;;=V43.1^^37^411^44
 ;;^UTILITY(U,$J,358.3,7136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7136,1,3,0)
 ;;=3^Pseudophakia
 ;;^UTILITY(U,$J,358.3,7136,1,4,0)
 ;;=4^V43.1
 ;;^UTILITY(U,$J,358.3,7136,2)
 ;;=^69114
 ;;^UTILITY(U,$J,358.3,7137,0)
 ;;=367.9^^37^411^46
 ;;^UTILITY(U,$J,358.3,7137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7137,1,3,0)
 ;;=3^Refractive Error
 ;;^UTILITY(U,$J,358.3,7137,1,4,0)
 ;;=4^367.9
 ;;^UTILITY(U,$J,358.3,7137,2)
 ;;=^35634
 ;;^UTILITY(U,$J,358.3,7138,0)
 ;;=365.04^^37^411^26
 ;;^UTILITY(U,$J,358.3,7138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7138,1,3,0)
 ;;=3^Glaucoma Ocular Hypertension
 ;;^UTILITY(U,$J,358.3,7138,1,4,0)
 ;;=4^365.04
 ;;^UTILITY(U,$J,358.3,7138,2)
 ;;=^85124
 ;;^UTILITY(U,$J,358.3,7139,0)
 ;;=365.01^^37^411^30
 ;;^UTILITY(U,$J,358.3,7139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7139,1,3,0)
 ;;=3^Glaucoma Suspect
 ;;^UTILITY(U,$J,358.3,7139,1,4,0)
 ;;=4^365.01
 ;;^UTILITY(U,$J,358.3,7139,2)
 ;;=^340633
 ;;^UTILITY(U,$J,358.3,7140,0)
 ;;=365.71^^37^411^24
 ;;^UTILITY(U,$J,358.3,7140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7140,1,3,0)
 ;;=3^Glaucoma Mild Stage
 ;;^UTILITY(U,$J,358.3,7140,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,7140,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,7141,0)
 ;;=365.72^^37^411^25
 ;;^UTILITY(U,$J,358.3,7141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7141,1,3,0)
 ;;=3^Glaucoma Moderate Stage
 ;;^UTILITY(U,$J,358.3,7141,1,4,0)
 ;;=4^365.72
 ;;^UTILITY(U,$J,358.3,7141,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,7142,0)
 ;;=365.73^^37^411^28
 ;;^UTILITY(U,$J,358.3,7142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7142,1,3,0)
 ;;=3^Glaucoma Severe Stage
 ;;^UTILITY(U,$J,358.3,7142,1,4,0)
 ;;=4^365.73
 ;;^UTILITY(U,$J,358.3,7142,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,7143,0)
 ;;=362.51^^37^411^1
 ;;^UTILITY(U,$J,358.3,7143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7143,1,3,0)
 ;;=3^AMD,Dry
 ;;^UTILITY(U,$J,358.3,7143,1,4,0)
 ;;=4^362.51
 ;;^UTILITY(U,$J,358.3,7143,2)
 ;;=^268636
 ;;^UTILITY(U,$J,358.3,7144,0)
 ;;=362.52^^37^411^2
 ;;^UTILITY(U,$J,358.3,7144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7144,1,3,0)
 ;;=3^AMD,Wet/Exudative
 ;;^UTILITY(U,$J,358.3,7144,1,4,0)
 ;;=4^362.52
 ;;^UTILITY(U,$J,358.3,7144,2)
 ;;=^268637
 ;;^UTILITY(U,$J,358.3,7145,0)
 ;;=362.04^^37^411^14
 ;;^UTILITY(U,$J,358.3,7145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7145,1,3,0)
 ;;=3^DM Mild NPDR
 ;;^UTILITY(U,$J,358.3,7145,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,7145,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,7146,0)
 ;;=362.05^^37^411^15
 ;;^UTILITY(U,$J,358.3,7146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7146,1,3,0)
 ;;=3^DM Moderate NPDR
 ;;^UTILITY(U,$J,358.3,7146,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,7146,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,7147,0)
 ;;=362.06^^37^411^17
 ;;^UTILITY(U,$J,358.3,7147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7147,1,3,0)
 ;;=3^DM Severe NPDR
 ;;^UTILITY(U,$J,358.3,7147,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,7147,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,7148,0)
 ;;=362.02^^37^411^16
 ;;^UTILITY(U,$J,358.3,7148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7148,1,3,0)
 ;;=3^DM PDR
 ;;^UTILITY(U,$J,358.3,7148,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,7148,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,7149,0)
 ;;=379.39^^37^411^45
 ;;^UTILITY(U,$J,358.3,7149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7149,1,3,0)
 ;;=3^Pseudophakia
 ;;^UTILITY(U,$J,358.3,7149,1,4,0)
 ;;=4^379.39
 ;;^UTILITY(U,$J,358.3,7149,2)
 ;;=^87515
 ;;^UTILITY(U,$J,358.3,7150,0)
 ;;=367.9^^37^411^18
 ;;^UTILITY(U,$J,358.3,7150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7150,1,3,0)
 ;;=3^Disorder of Refraction
 ;;^UTILITY(U,$J,358.3,7150,1,4,0)
 ;;=4^367.9
 ;;^UTILITY(U,$J,358.3,7150,2)
 ;;=^35634
 ;;^UTILITY(U,$J,358.3,7151,0)
 ;;=373.2^^37^411^35
 ;;^UTILITY(U,$J,358.3,7151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7151,1,3,0)
 ;;=3^Meibomianitis
 ;;^UTILITY(U,$J,358.3,7151,1,4,0)
 ;;=4^373.2
 ;;^UTILITY(U,$J,358.3,7151,2)
 ;;=^22156
 ;;^UTILITY(U,$J,358.3,7152,0)
 ;;=V58.69^^37^411^33
 ;;^UTILITY(U,$J,358.3,7152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7152,1,3,0)
 ;;=3^Long Term Use of Medication
 ;;^UTILITY(U,$J,358.3,7152,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,7152,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,7153,0)
 ;;=379.24^^37^411^51
 ;;^UTILITY(U,$J,358.3,7153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7153,1,3,0)
 ;;=3^Vitreous Floaters
 ;;^UTILITY(U,$J,358.3,7153,1,4,0)
 ;;=4^379.24
 ;;^UTILITY(U,$J,358.3,7153,2)
 ;;=^88242
 ;;^UTILITY(U,$J,358.3,7154,0)
 ;;=V80.2^^37^411^47
 ;;^UTILITY(U,$J,358.3,7154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7154,1,3,0)
 ;;=3^Screening for Eye Condition
 ;;^UTILITY(U,$J,358.3,7154,1,4,0)
 ;;=4^V80.2
 ;;^UTILITY(U,$J,358.3,7154,2)
 ;;=^295685
 ;;^UTILITY(U,$J,358.3,7155,0)
 ;;=V70.5^^37^411^48
 ;;^UTILITY(U,$J,358.3,7155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7155,1,3,0)
 ;;=3^Screening,Occupational
 ;;^UTILITY(U,$J,358.3,7155,1,4,0)
 ;;=4^V70.5
 ;;^UTILITY(U,$J,358.3,7155,2)
 ;;=^295595
 ;;^UTILITY(U,$J,358.3,7156,0)
 ;;=365.11^^37^411^27
 ;;^UTILITY(U,$J,358.3,7156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7156,1,3,0)
 ;;=3^Glaucoma Primary Open Angle
 ;;^UTILITY(U,$J,358.3,7156,1,4,0)
 ;;=4^365.11
 ;;^UTILITY(U,$J,358.3,7156,2)
 ;;=^51203
 ;;^UTILITY(U,$J,358.3,7157,0)
 ;;=365.70^^37^411^29
 ;;^UTILITY(U,$J,358.3,7157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7157,1,3,0)
 ;;=3^Glaucoma Stage NOS
 ;;^UTILITY(U,$J,358.3,7157,1,4,0)
 ;;=4^365.70
 ;;^UTILITY(U,$J,358.3,7157,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,7158,0)
 ;;=365.74^^37^411^23
 ;;^UTILITY(U,$J,358.3,7158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7158,1,3,0)
 ;;=3^Glaucoma Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,7158,1,4,0)
 ;;=4^365.74
 ;;^UTILITY(U,$J,358.3,7158,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,7159,0)
 ;;=92015^^38^412^1^^^^1
 ;;^UTILITY(U,$J,358.3,7159,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7159,1,2,0)
 ;;=2^Refraction
 ;;^UTILITY(U,$J,358.3,7159,1,3,0)
 ;;=3^92015
 ;;^UTILITY(U,$J,358.3,7160,0)
 ;;=92311^^38^413^3^^^^1
 ;;^UTILITY(U,$J,358.3,7160,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7160,1,2,0)
 ;;=2^Contact Lens-Aphakia OD/OS
 ;;^UTILITY(U,$J,358.3,7160,1,3,0)
 ;;=3^92311
 ;;^UTILITY(U,$J,358.3,7161,0)
 ;;=92312^^38^413^4^^^^1
 ;;^UTILITY(U,$J,358.3,7161,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7161,1,2,0)
 ;;=2^Contact Lens-Aphakia OU
 ;;^UTILITY(U,$J,358.3,7161,1,3,0)
 ;;=3^92312
 ;;^UTILITY(U,$J,358.3,7162,0)
 ;;=92340^^38^413^6^^^^1
 ;;^UTILITY(U,$J,358.3,7162,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7162,1,2,0)
 ;;=2^Glasses Fitting, Monofocal
 ;;^UTILITY(U,$J,358.3,7162,1,3,0)
 ;;=3^92340
 ;;^UTILITY(U,$J,358.3,7163,0)
 ;;=92341^^38^413^5^^^^1
 ;;^UTILITY(U,$J,358.3,7163,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7163,1,2,0)
 ;;=2^Glasses Fitting, Bifocal
 ;;^UTILITY(U,$J,358.3,7163,1,3,0)
 ;;=3^92341
 ;;^UTILITY(U,$J,358.3,7164,0)
 ;;=92342^^38^413^8^^^^1
 ;;^UTILITY(U,$J,358.3,7164,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7164,1,2,0)
 ;;=2^Glasses Fitting, Multifocal
 ;;^UTILITY(U,$J,358.3,7164,1,3,0)
 ;;=3^92342
 ;;^UTILITY(U,$J,358.3,7165,0)
 ;;=92352^^38^413^7^^^^1
 ;;^UTILITY(U,$J,358.3,7165,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7165,1,2,0)
 ;;=2^Glasses Fitting, Monofocal for Aphakia
 ;;^UTILITY(U,$J,358.3,7165,1,3,0)
 ;;=3^92352
 ;;^UTILITY(U,$J,358.3,7166,0)
 ;;=92353^^38^413^9^^^^1
 ;;^UTILITY(U,$J,358.3,7166,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7166,1,2,0)
 ;;=2^Glasses Fitting, Multifocal, for Aphakia
 ;;^UTILITY(U,$J,358.3,7166,1,3,0)
 ;;=3^92353
